Prevalence of hepatitis C virus in the Mexican population: a systematic review
- PMID: 18343505
- DOI: 10.1016/j.jinf.2008.02.001
Prevalence of hepatitis C virus in the Mexican population: a systematic review
Abstract
Background: Although hepatitis C virus (HCV) infection is considered a relevant public health problem in Mexico, the prevalence is still under discussion. The objective of this study was to conduct a systematic review to explore the prevalence of HCV infection in the Mexican population.
Methods: A systematic review of studies reporting prevalence in Mexican population was performed using several free-access databases.
Results: Sixty-eight works fulfilled the search criteria. From these, 44 studies involved asymptomatic subjects and 28 involved patients or high-risk subjects. Prevalence of blood donors (6,955,558 persons) ranged from 0.0% to 2.05%, with 7/32 studies reporting values >1%, whereas prevalence of non-donor asymptomatic subjects (28,528 persons) from 0.0% to 2.7%, with 7/11 studies reporting values >1%, and medical personnel from 0.0% to 2.08% (1,227 persons), with 4/11 studies reporting values >1%. Prevalence of patients with chronic hepatic disease ranged from 6.7% to 77%. The most prevalent genotype was 1 (30.0-87.5%), of which subtype 1b is the most frequent (11.9-61.9%). The main risk factors were blood transfusion and unprotected sex or having multiple sex partners.
Conclusions: The prevalence in the Mexican population seems to be in accordance with that previously estimated by the World Health Organization (1-2.5%).
Similar articles
-
Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review.Intervirology. 2007;50(1):1-8. doi: 10.1159/000096306. Epub 2006 Nov 24. Intervirology. 2007. PMID: 17164551
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
-
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240. Health Technol Assess. 2006. PMID: 16796930
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
-
Direct-acting antivirals for chronic hepatitis C.Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3. Cochrane Database Syst Rev. 2017. PMID: 28922704 Free PMC article.
Cited by
-
Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi'an, China.Virol J. 2010 Aug 10;7:186. doi: 10.1186/1743-422X-7-186. Virol J. 2010. PMID: 20698949 Free PMC article.
-
Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative.Pathogens. 2024 Oct 1;13(10):859. doi: 10.3390/pathogens13100859. Pathogens. 2024. PMID: 39452730 Free PMC article. Review.
-
Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3106-18. doi: 10.1158/1055-9965.EPI-10-0863. Epub 2010 Oct 12. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20940276 Free PMC article.
-
Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project, 2000-2009.J Immigr Minor Health. 2013 Apr;15(2):390-7. doi: 10.1007/s10903-012-9604-8. J Immigr Minor Health. 2013. PMID: 22447176 Free PMC article.
-
Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America.World J Gastroenterol. 2016 Jun 14;22(22):5137-42. doi: 10.3748/wjg.v22.i22.5137. World J Gastroenterol. 2016. PMID: 27298556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical